Showing 2,261 - 2,280 results of 9,103 for search 'significant ((((((gap decrease) OR (step decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.64s Refine Results
  1. 2261

    Analyses of directed phase lag index (dPLI [44]) for excitatory/inhibitory (E/I) ratios with respect to pyramidal (Pyr) and parvalbumin (PV) populations (<i>A</i>) and Pyr and soma... by Nobuhiko Wagatsuma (494052)

    Published 2025
    “…<p>Black circles and gray pentagons represent the mean values of dPLI from PV to Pyr and from SOM to Pyr populations, respectively. …”
  2. 2262

    Uptake of the intervention (N = 49). by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  3. 2263

    Baseline characteristics of sample by trial arm. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  4. 2264

    CweL trial design. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  5. 2265

    Participant Flow. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  6. 2266

    Economic cost composition by arm and outcomes. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  7. 2267

    S1 File - by Vasanthi Avadhanula (259546)

    Published 2025
    “…Cases included SARS-CoV-2 infected individuals with extremely high viral loads early in their illness, individuals having low SARS-CoV-2 viral loads early in their infection, and individuals testing negative for SARS-CoV-2. We could identify widespread transcriptional host responses to SARS-CoV-2 infection that were initially most strongly manifested in patients with extremely high initial viral loads, then attenuating within the patient over time as viral loads decreased. …”
  8. 2268

    Minimal data set. by Xiaoxia Liu (294088)

    Published 2024
    “…Using the multiple scale method, we derive approximate analytical solutions for both the crystal interface growth rate and the solute concentration. …”
  9. 2269

    Cascade of care by HCV testing model. by Bao Vu Ngoc (14551955)

    Published 2025
    “…We engaged eight community-based organizations (CBOs) and 10 public and private clinics in offering HCVST using oral fluid-based HCV rapid antibody tests along with standard or provider-led HCV testing (HCVT). …”
  10. 2270
  11. 2271

    Factors associated with first-time HCV testing. by Bao Vu Ngoc (14551955)

    Published 2025
    “…We engaged eight community-based organizations (CBOs) and 10 public and private clinics in offering HCVST using oral fluid-based HCV rapid antibody tests along with standard or provider-led HCV testing (HCVT). …”
  12. 2272

    Model parameters. by Nan Zhang (46264)

    Published 2024
    “…In contrast, comparing with no hand washing, handwashing every 2 hours can reduce the infection risk per visit to the airport by only 2.0%, making public surface disinfection significantly more effective than handwashing. If the mask-wearing rate increases from 0% to 50%, the infection risk of norovirus would be decreased by 48.0% (95% CI, 43.5–52.3%). …”
  13. 2273

    Structure-Affinity-Pharmacokinetics Relationships of Novel <sup>18</sup>F‑Labeled 1,4-Diazepane Derivatives for Orexin 1 Receptor Imaging by Yui Ishizaka (19922137)

    Published 2024
    “…In a biodistribution study using normal mice, [<sup>18</sup>F]­BTF exhibited brain uptake, and radioactivity in the brain was significantly decreased by preinjection of unlabeled BTF. …”
  14. 2274
  15. 2275
  16. 2276

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  17. 2277

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  18. 2278
  19. 2279
  20. 2280